| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-05 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-05 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-05 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.3 | 4e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-05 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-05 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-05 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-05 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-05 |